Blood THC After Smoking: Three Analytes, Three Different Timelines

A cannabinoid result is not just a number. It is an analyte measured in a particular specimen at a particular time.

Controlled research shows why those details matter. After smoked cannabis, parent THC enters blood within minutes, reaches its highest concentration during smoking, and then falls rapidly. The active metabolite 11-OH-THC appears at lower concentrations. The inactive carboxy metabolite THC-COOH rises later and remains detectable longer.

Those three curves answer different questions. Treating them as interchangeable can turn a correct laboratory measurement into an unsupported timeline.

What the controlled study did

Huestis, Henningfield, and Cone studied six healthy male volunteers with histories of marijuana use on a closed research ward. Each participant completed three weekly sessions using a placebo cigarette, a 1.75 percent THC cigarette, or a 3.55 percent THC cigarette. The order was randomized, double blind, and arranged as a Latin-square crossover.

The active cigarettes delivered approximately 15.8 and 33.8 mg THC. Participants followed a paced smoking procedure involving eight puffs over 11.2 minutes.

The study's unusual strength was its sampling density. An automated withdrawal system collected blood at one-minute intervals during smoking, then at progressively wider intervals afterward. The investigators obtained thirty-four plasma samples from the start of smoking through seven days.

The samples were tested by gas chromatography-mass spectrometry for parent delta-9 THC, active 11-hydroxy-THC, and inactive 11-nor-9-carboxy-THC. For analytical context, see Cannabis Metabolites in Toxicology and Drug Metabolism in Toxicology.

Parent THC peaked before smoking ended

Plasma THC concentrations rose almost immediately after inhalation. The study found that peak THC occurred before participants finished the cigarette.

That timing is easy to miss in studies that draw the first blood sample after smoking is complete. A specimen collected several minutes later can already be on the steep distribution phase, when the measured plasma concentration is falling rapidly even though the exposure was recent.

The decrease does not mean the body eliminated all of the THC during those minutes. After entering the circulation, THC distributes into tissues. The concentration in a sampled blood compartment can therefore fall quickly because of distribution as well as metabolism and elimination.

See Drug Absorption and Toxicology Results and Drug Distribution in Forensic Toxicology.

11-OH-THC followed a lower curve

The active metabolite 11-OH-THC followed a different pattern. Mean peak concentrations were substantially lower than the parent-THC peaks and occurred immediately after smoking ended.

Parent THC and 11-OH-THC are different compounds with different concentration ranges and time courses. A method that reports only one cannabinoid does not provide the same information as a panel that identifies the parent compound and metabolites separately.

The route also matters. This study examined inhalation. Oral cannabis undergoes more extensive first-pass metabolism and produces a different relationship among THC, 11-OH-THC, dose, and time. The smoking curve should not be copied onto an edible-cannabis case.

THC-COOH rose slowly and lasted longer

THC-COOH did not mirror the rapid parent-THC peak. It increased gradually, reached a mean peak at 113 minutes, and plateaued for a longer period. Its detection course extended well beyond the parent compound and active metabolite.

THC-COOH is evidence of metabolism. Because it is inactive and persists longer, its presence does not establish that the person was experiencing a contemporaneous psychoactive effect at the time of an earlier event.

This is why the reported analyte must be identified precisely. A result labeled only as "cannabinoids" or "marijuana metabolite" hides the difference between recent circulating parent THC and a metabolite with a longer detection window.

For the broader distinction, see Detection Windows in Forensic Toxicology.

Collection delay changes the evidentiary picture

In an impaired-driving or workplace investigation, the specimen is rarely collected at the moment of the alleged conduct. The delay may include the stop, questioning, field exercises, transportation, medical clearance, warrant process, phlebotomy, and documentation.

During that interval, parent THC can fall sharply. The later blood result is a measurement at collection time, not a direct measurement of the concentration at the earlier event.

Reconstructing an earlier value is not a simple arithmetic exercise. The curve is influenced by route, smoking behavior, dose, inhalation depth, product potency, frequency of use, tissue distribution, and the specimen matrix. A single later concentration does not reveal all of those inputs.

The correct timeline should separately document the start and end of reported cannabis use, the alleged event, the first observation, each examination, the specimen collection, and the laboratory analysis.

Plasma is not whole blood

The Huestis study measured plasma. Many forensic laboratories report cannabinoids in whole blood. Plasma and whole blood are not numerically interchangeable.

Before comparing a case result with this study, identify the matrix reported by both the laboratory and the publication. A comparison based only on the shared unit ng/mL can be misleading if one value is plasma and the other is whole blood.

See Whole Blood vs. Plasma Toxicology Results and Biological Matrices in Toxicology.

What the study did not establish

This was a pharmacokinetic study. It described how three cannabinoids appeared and changed in plasma during and after controlled smoking. It did not establish a universal THC concentration that proves impairment, a concentration that proves when a person last used cannabis, or a conversion formula from a later plasma result to an earlier whole-blood result.

The study also does not supply the same timeline for oral, sublingual, topical, or vaporized products, or a population-wide result from six male participants. The paper provides a detailed controlled curve. Case interpretation still requires the actual specimen, method, timeline, and individual evidence.

Records needed for a case-specific review

1. The reported product, potency, amount, route, and start and stop times of use.
2. The person's use frequency, tolerance, medical use, and prior exposure.
3. The exact event, observation, examination, arrest, and collection times.
4. The specimen matrix and the laboratory's basis for reporting whole blood, plasma, or serum.
5. The complete analytical method, validation, calibration range, controls, chromatograms, and reporting limits.
6. Separate results for THC, 11-OH-THC, THC-COOH, and any other cannabinoids measured.
7. Storage, transport, stability, dilution, reinjection, and repeat-analysis records.
8. Alcohol, medications, and other drugs that could affect performance or interpretation.
9. The scientific basis for any extrapolation to an earlier time.
10. The uncertainty attached to the measured result and to every later inference.

See Measurement Uncertainty in Toxicology for the difference between analytical uncertainty and interpretive uncertainty.

The bottom line

In this controlled smoking study, plasma THC rose within minutes, peaked before smoking ended, and fell rapidly. The active metabolite 11-OH-THC remained much lower and peaked immediately after smoking. The inactive THC-COOH metabolite rose more slowly, reached its mean peak at 113 minutes, and persisted longer.

The forensic meaning of a cannabinoid result depends on which compound was measured, in which matrix, and how long after the event the specimen was collected. A number without that timeline is incomplete evidence.

Primary source

Huestis MA, Henningfield JE, Cone EJ. Blood Cannabinoids I: Absorption of THC and Formation of 11-OH-THC and THCCOOH During and After Smoking Marijuana. Journal of Analytical Toxicology. 1992;16(5):276-282. Oxford Academic journal record. doi:10.1093/jat/16.5.276.

Editorial note: This article paraphrases the published research. The source PDF, publisher layout, tables, and figures are not reproduced.